SARS-CoV-2 Induces Cytokine Responses in Human Basophils

Front Immunol. 2022 Feb 24:13:838448. doi: 10.3389/fimmu.2022.838448. eCollection 2022.

Abstract

Basophils play a key role in the orientation of immune responses. Though the interaction of SARS-CoV-2 with various immune cells has been relatively well studied, the response of basophils to this pandemic virus is not characterized yet. In this study, we report that SARS-CoV-2 induces cytokine responses and in particular IL-13, in both resting and IL-3 primed basophils. The response was prominent under IL-3 primed condition. However, either SARS-CoV-2 or SARS-CoV-2-infected epithelial cells did not alter the expression of surface markers associated with the activation of basophils, such as CD69, CD13 and/or degranulation marker CD107a. We also validate that human basophils are not permissive to SARS-CoV-2 replication. Though increased expression of immune checkpoint molecule PD-L1 has been reported on the basophils from COVID-19 patients, we observed that SARS-CoV-2 does not induce PD-L1 on the basophils. Our data suggest that basophil cytokine responses to SARS-CoV-2 might help in reducing the inflammation and also to promote antibody responses to the virus.

Keywords: basophils; COVID-19; Caco-2 cells; IL-13; IL-3; IL-4; SARS-CoV-2; epithelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B7-H1 Antigen / metabolism
  • Basophils / immunology*
  • Biomarkers / metabolism
  • COVID-19 / immunology*
  • Cells, Cultured
  • Humans
  • Interleukin-13 / metabolism*
  • Interleukin-3 / metabolism
  • SARS-CoV-2 / physiology*
  • Virus Replication

Substances

  • B7-H1 Antigen
  • Biomarkers
  • Interleukin-13
  • Interleukin-3